ID: ALA2289034

Max Phase: Preclinical

Molecular Formula: C15H9ClFN3OS

Molecular Weight: 333.78

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1nnc(-c2ccc(Cl)cc2)s1)c1ccccc1F

Standard InChI:  InChI=1S/C15H9ClFN3OS/c16-10-7-5-9(6-8-10)14-19-20-15(22-14)18-13(21)11-3-1-2-4-12(11)17/h1-8H,(H,18,20,21)

Standard InChI Key:  RWLSLUBOLLWKBF-UHFFFAOYSA-N

Associated Targets(non-human)

Chilo suppressalis 440 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 333.78Molecular Weight (Monoisotopic): 333.0139AlogP: 4.25#Rotatable Bonds: 3
Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.86CX Basic pKa: CX LogP: 4.30CX LogD: 4.17
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: -2.60

References

1. NAKAGAWA Y, NISHIMURA K, IZUMI K, KINOSHITA K, KIMURA T, KURIHARA N, FUJITA T.  (1996)  Quantitative Structure-Activity Relationships of Larvicidal N-[5-(Substituted phenyl)-1, 3, 4-thiadiazol-2-yl]-benzamides in the Inhibition of N-Acetylglucosamine Incorporation into a Cultured Integument System,  21  (2): [10.1584/jpestics.21.195]

Source